RER-CTO Reinforce the Ethical and Regulatory Ecosystem for the Transformation of Clinical Trials Oversight in Ethiopia, Tanzania and beyond
- Coordinator
- Universitetet I Oslo, Norway
- Runs
- 1 July 2024 to 30 June 2027
- Status
- Running
- EU funding
- €926k
- Total cost
- €926k
- Partners
- 7 organisations in 4 countries
- Type
- Coordination and Support Action
- Grant agreement
- 101145815
What the project is doing
In the project's own words, from its summary on CORDIS.
Why RER-CTO?: The conduct of clinical trials requires competent ethics committee and regulatory authorities that can review clinical trial applications and monitor processes independently and efficiently ensuring the safety of clinical trial participants, and the integrity and reliability of the generated data. The capacity of most African regulatory authorities regarding clinical trial review and oversight is weak due to poor infrastructure, limited resources both human and financial, lack of expertise, un-conducive working framework and lack of systems adequately supported by technology.
Collaboration between academia, international organizations, National ethics committees (NECs) and national regulatory authorities (NRAs) are mandatory to produce sustainable regulatory skills and functional clinical trial oversight systems. The RER-CTO consortium consists of a group of well reputable clinical trial researchers, regulatory authorities, ethics committees, universities and research institutes in Ethiopia, Tanzania, Norway, and Sweden.
Our aim is to achieve ethics and regulatory excellence and harmonization in sub-Saharan Africa in clinical trial oversight (CTO) by improving the legal and policy framework by identifying gaps and making recommendations, improving regulatory and research ethics oversight capacity and capability by digitalising the clinical trial oversight systems and developing training programs to strengthen competency of relevant stakeholders, and strengthening local, regional, and international collaborations and coordination of NECs and NRAs for clinical trial oversight by developing joint clinical trial review guidelines.
These efforts are geared towards increasing clinical trials in sub-Saharan Africa, standardization of clinical trial review and monitoring processes, and promoting ownership, efficiency, linkages for data sharing, transparency, and accountability of clinical trial review processes.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Universitetet I Oslo | Oslo | Norway | Coordinator |
| Armauer Hansen Research Institute | Addis Ababa | ET | Participant |
| Ethiopian Food and Drug Authority | Addis Ababa | ET | Participant |
| Ministry of Education of Federal Republic of Ethiopia, | Addis Ababa | ET | Participant |
| Karolinska Institutet | Stockholm | Sweden | Participant |
| National Institute for Medical Research | Dar Es Salaam | TZ | Participant |
| Tanzania Medicines and Medical Devices Authourity | Dar Es Salaam | TZ | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI